Schuette Verena, Embgenbroich Maria, Ulas Thomas, Welz Meike, Schulte-Schrepping Jonas, Draffehn Astrid M, Quast Thomas, Koch Katharina, Nehring Melanie, König Jessica, Zweynert Annegret, Harms Frederike L, Steiner Nancy, Limmer Andreas, Förster Irmgard, Berberich-Siebelt Friederike, Knolle Percy A, Wohlleber Dirk, Kolanus Waldemar, Beyer Marc, Schultze Joachim L, Burgdorf Sven
Life and Medical Sciences Institute, University of Bonn, 53115 Bonn, Germany;
Clinic for Orthopaedics and Trauma Surgery, University Hospital Bonn, 53127 Bonn, Germany;
Proc Natl Acad Sci U S A. 2016 Sep 20;113(38):10649-54. doi: 10.1073/pnas.1605885113. Epub 2016 Sep 6.
The mannose receptor (MR) is an endocytic receptor involved in serum homeostasis and antigen presentation. Here, we identify the MR as a direct regulator of CD8(+) T-cell activity. We demonstrate that MR expression on dendritic cells (DCs) impaired T-cell cytotoxicity in vitro and in vivo. This regulatory effect of the MR was mediated by a direct interaction with CD45 on the T cell, inhibiting its phosphatase activity, which resulted in up-regulation of cytotoxic T-lymphocyte-associated Protein 4 (CTLA-4) and the induction of T-cell tolerance. Inhibition of CD45 prevented expression of B-cell lymphoma 6 (Bcl-6), a transcriptional inhibitor that directly bound the CTLA-4 promoter and regulated its activity. These data demonstrate that endocytic receptors expressed on DCs contribute to the regulation of T-cell functionality.
甘露糖受体(MR)是一种参与血清稳态和抗原呈递的内吞受体。在此,我们确定MR是CD8(+) T细胞活性的直接调节因子。我们证明,树突状细胞(DC)上的MR表达在体外和体内均损害T细胞的细胞毒性。MR的这种调节作用是通过与T细胞上的CD45直接相互作用介导的,抑制其磷酸酶活性,从而导致细胞毒性T淋巴细胞相关蛋白4(CTLA-4)上调并诱导T细胞耐受。抑制CD45可阻止B细胞淋巴瘤6(Bcl-6)的表达,Bcl-6是一种转录抑制剂,可直接结合CTLA-4启动子并调节其活性。这些数据表明,DC上表达的内吞受体有助于调节T细胞功能。